3-(2,2,2-trimethylhydrazine)propionate has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calarco, A; Di Cristo, F; Digilio, FA; Galderisi, U; Melone, MAB; Peluso, G; Rosano, C; Saturnino, C; Sinicropi, MS | 1 |
| D'Apolito, M; Di Cristo, F; Digilio, FA; Finicelli, M; Galderisi, U; Giordano, A; Melone, MAB; Paladino, S; Peluso, G; Saturnino, C; Scialò, F; Valentino, A | 1 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Huntington Disease
| Article | Year |
|---|---|
The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity.
Topics: Animals; Carnitine; Cell Line; Cell Survival; Disease Models, Animal; Drosophila melanogaster; Drug Evaluation, Preclinical; Humans; Huntington Disease; Longevity; Methylhydrazines; Mice; Molecular Docking Simulation; Protein Aggregation, Pathological; Signal Transduction; Solute Carrier Family 22 Member 5; Transfection; Treatment Outcome | 2020 |
Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression.
Topics: Animals; Animals, Genetically Modified; Cell Death; Cell Line; Culture Media, Serum-Free; Disease Models, Animal; Drosophila; Humans; Huntingtin Protein; Huntington Disease; Methylhydrazines; Mitochondria; Models, Biological; Mutation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Aggregates; Reactive Oxygen Species; Survival Analysis; Up-Regulation | 2019 |